484 related articles for article (PubMed ID: 28886003)
1. Functional precision cancer medicine-moving beyond pure genomics.
Letai A
Nat Med; 2017 Sep; 23(9):1028-1035. PubMed ID: 28886003
[TBL] [Abstract][Full Text] [Related]
2. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
3. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
4. Bringing precision medicine to the clinic: from genomic profiling to the power of clinical observation.
Baselga J
Ann Oncol; 2013 Aug; 24(8):1956-7. PubMed ID: 23878114
[No Abstract] [Full Text] [Related]
5. Widespread Genomic Testing Deemed Feasible.
Cancer Discov; 2017 Aug; 7(8):786-787. PubMed ID: 28642250
[TBL] [Abstract][Full Text] [Related]
6. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
7. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
8. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine for cancer with next-generation functional diagnostics.
Friedman AA; Letai A; Fisher DE; Flaherty KT
Nat Rev Cancer; 2015 Dec; 15(12):747-56. PubMed ID: 26536825
[TBL] [Abstract][Full Text] [Related]
10. Genetically InFormed therapies--a "GIFT" for children with cancer.
Thiele CJ; Cohn SL
Clin Cancer Res; 2012 May; 18(10):2735-9. PubMed ID: 22589482
[TBL] [Abstract][Full Text] [Related]
11. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
12. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
[TBL] [Abstract][Full Text] [Related]
13. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
Bryce AH; Egan JB; Borad MJ; Stewart AK; Nowakowski GS; Chanan-Khan A; Patnaik MM; Ansell SM; Banck MS; Robinson SI; Mansfield AS; Klee EW; Oliver GR; McCormick JB; Huneke NE; Tagtow CM; Jenkins RB; Rumilla KM; Kerr SE; Kocher JA; Beck SA; Fernandez-Zapico ME; Farrugia G; Lazaridis KN; McWilliams RR
Oncotarget; 2017 Apr; 8(16):27145-27154. PubMed ID: 28423702
[TBL] [Abstract][Full Text] [Related]
14. Genomics and bioinformatics as pillars of precision medicine in oncology.
Canzoneri R; Lacunza E; Abba MC
Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
[TBL] [Abstract][Full Text] [Related]
15. Cancer genomics guide clinical practice in personalized medicine.
Lehmann-Che J; Poirot B; Boyer JC; Evrard A
Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
[TBL] [Abstract][Full Text] [Related]
16. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
Tsimberidou AM
Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
[TBL] [Abstract][Full Text] [Related]
17. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine in pediatric oncology: Lessons learned and next steps.
Mody RJ; Prensner JR; Everett J; Parsons DW; Chinnaiyan AM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27748023
[TBL] [Abstract][Full Text] [Related]
19. Exploiting rare driver mutations for precision cancer medicine.
Scholl C; Fröhling S
Curr Opin Genet Dev; 2019 Feb; 54():1-6. PubMed ID: 30844512
[TBL] [Abstract][Full Text] [Related]
20. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
[Next] [New Search]